About Salvia BioElectronics
Salvia BioElectronics is a company based in Eindhoven (Netherlands) founded in 2017 by Wim Pollet. Salvia BioElectronics has raised $88.4 million across 5 funding rounds from investors including Jazz Pharmaceuticals, Imec and Rijksdienst voor Ondernemend Nederland. Salvia BioElectronics offers products and services including Migraine Implant and Bioelectronic Therapy. Salvia BioElectronics operates in a competitive market with competitors including ElectroCore, ShiraTronics, eNeura, Cefaly and Zosano Pharma, among others.
- Headquarter Eindhoven, Netherlands
- Founders Wim Pollet
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Salvia Bioelectronics B.V.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$88.4 M (USD)
in 5 rounds
-
Latest Funding Round
$60 M (USD), Series B
May 27, 2025
-
Investors
Jazz Pharmaceuticals
& 12 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Salvia BioElectronics
Salvia BioElectronics offers a comprehensive portfolio of products and services, including Migraine Implant and Bioelectronic Therapy.
Implantable solution for treating chronic migraine in clinical studies.
Personalized device for neurological disorder management.
Funding Insights of Salvia BioElectronics
Salvia BioElectronics has successfully raised a total of $88.4M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $60 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Salvia BioElectronics
Salvia BioElectronics has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Jazz Pharmaceuticals, Imec and Rijksdienst voor Ondernemend Nederland.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Healthcare-focused private equity investments are managed by SHS Capital.
|
Locked | Locked | Locked | |
|
Investments are directed by BOM toward early and growth-stage firms.
|
Locked | Locked | Locked |
Investor details for Salvia BioElectronics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Salvia BioElectronics
Investment portfolio details for Salvia BioElectronics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Salvia BioElectronics
Detailed financials for Salvia BioElectronics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Salvia Bioelectronics Comparisons
Peer comparison for Salvia BioElectronics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Salvia BioElectronics
Salvia BioElectronics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ElectroCore, ShiraTronics, eNeura, Cefaly and Zosano Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive vagus nerve stimulation devices are developed for headache treatments.
|
|
| Locked | Locked | Locked |
Neuromodulation devices for migraine and chronic disease treatment are developed.
|
|
| Locked | Locked | Locked |
Transcranial magnetic stimulation devices for migraine treatment are developed.
|
|
| Locked | Locked | Locked |
Neurostimulation devices for migraine and headache treatment are provided.
|
|
| Locked | Locked | Locked |
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
|
Detailed competitors of Salvia BioElectronics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Salvia Bioelectronics
Complete news archive for Salvia BioElectronics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Salvia BioElectronics
Salvia BioElectronics was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Salvia BioElectronics is headquartered in Eindhoven, Netherlands. It is registered at Eindhoven, Noord-brabant, Netherlands.
Salvia BioElectronics is a funded company, having raised a total of $88.4M across 5 funding rounds to date.
Salvia BioElectronics was founded in 2017 in Eindhoven, Netherlands, within the bioelectronics sector. Neuromodulation therapies are developed to address migraines and other neurological conditions. A thin implant has been created to deliver electrical pulses to relevant nerves, with the goal of reducing migraine frequency and severity. Operations focus on enhancing patient outcomes through targeted bioelectronic interventions in the European market.
Salvia BioElectronics's top competitors include ShiraTronics, ElectroCore and eNeura.
Salvia BioElectronics offers Migraine Implant and Bioelectronic Therapy.
Salvia BioElectronics has 13 investors. Key investors include Jazz Pharmaceuticals, Imec, Rijksdienst voor Ondernemend Nederland, European Union, and BOM.